Yates et al. 12 In contrast PBMC from patients with AIHA failed bone marrow. Chimeric mice generated from PBMC of these to reconstitute SCID mice and to produce autoantibodies. In our present study we tested whether the human/mouse between the B cell expansion and the autoimmune hemolytic radiation chimera could be engrafted by PBMC from AIHA Bprocess.
Introduction

Materials and methods
Chronic lymphocytic leukemia (CLL) is caused by malignant
Mice transformation of small mature B lymphocytes, characterized by the expression of low surface immunoglobulins as well as BALB/c mice (4-8 weeks old) were obtained from Olac Farms the CD5 antigen. [1] [2] [3] Clonality is suggested by the expression (Bicester, UK), NOD/SCID mice (4-6 weeks old) from the of a single immunoglobulin light chain, either or on the Weizmann Institute Animal Breeding Center (Rehovot, Israel). CLL cells surface membrane.
1 CLL patients often demonstrate All mice were kept in small cages (five animals in each cage) features of autoimmunity.
1 Approximately 10-20% of these and fed sterile food and acid water containing ciprofloxacin patients develop autoimmune hemolytic anemia (AIHA) or a (20 g/ml). positive direct anti-globulin test (DAT) during the course of their disease. 2 The origin of the autoantibodies causing the hemolysis and the mechanisms responsible for the developConditioning regimen ment of autoimmune phenomenon in CLL patients remain unclear. It is possible that the neoplastic B lymphocytes dis-BALB/c mice were exposed to total body irradiation (TBI), rupt control mechanisms of the immune network causing profrom a gamma beam 150-A 60 Co source (produced by the duction of polyclonal autoantibodies by normal, not leuAtomic Energy of Canada, Kanata, Ontario) with FSD of 75 cm kemic, lymphocytes. In contrast, the autoantibodies may be and a dose rate of 4 Gy followed 3 days later by 10 Gy monoclonal antibodies produced by the malignant B cell (split dose In patient No. 15, E-rosetting-depleted PBMC were transTo detect human Ig G antibody to human red blood cells planted into the recipient mice.
(RBC) in human-mouse chimera, we performed an indirect Coombs' test. In round-bottomed tubes 100 l of sera was mixed with 100 l of 1% papain-treated group O RBC. After
Immunization of chimeric mice a 1 h incubation at 37°C, the RBC were washed three times with PBS (pH 7.2) and then incubated with 50 l of rabbit Tetanus toxoid (TT) for immunization was a commercial TT anti-human IgG (Gamma Biological, Houston, TX, USA). Posivaccine from RAFA Laboratories Ltd (Jerusalem, Israel).
tive agglutination is scored after 1 hour of incubation at room temperature.
Cells and plasma collection from human/mouse chimera Serum electrophoresis and immunofixation Animals were bled from the retro-orbital vein using heparinElectrophoresis and immunofixation were performed on coated glass capillaries. Plasma was kept for human-Ig deterserum samples, maintained at −20°C until use, using commermination. Peritoneal cells were obtained by lavage with 10 ml cially available kits (Selenus Immunofixation Kit; Selenus Lab-PBS and cells were then isolated using Lymphoprep.
oratories, Hawthorn, Australia).
FACS analysis of donors PBMC and human cell Statistical analysis engraftment in chimeric mice
Statistical analysis was performed using the StatView II ProSingle cell suspensions were incubated for 30 min on ice with gram (Abacus Concepts, Berkeley, CA, USA) on a Macintosh a mixture of appropriate fluorescently labeled monoclonal IICi. 2 were utilized to calculate probability (P) values. Patients' characteristics are depicted in Table 1 . PBMC from 11 B-CLL patients with different manifestations of AIHA, from antibodies were purchased from Becton Dickinson. four B-CLL patients without AIHA, and splenic cells from one While human/mouse chimera generated by transplanting non-CLL AIHA patient, were infused into lethally irradiated splenic cells from patients with idiopathic AIHA produced a Balb/c mice radioprotected with SCID bone marrow.
high level of human antibodies (Table 1) patients who were positive in the Coombs' test, demonstrated For the evaluation of human cell engraftment in the substantial anti-human red cell antibodies in their serum human/mouse chimera, mice from four donors were sacrificed (P Ͻ 0.001) ( Table 1 ). In patient No. 8 repeated analysis failed in the present study 14 days after B-CLL transplantation and to detect IgG on the red blood cells surface and only C3d peritoneal washes as well as internal organs were analyzed specificity was found. However the chimeric mice generated by FACS for the presence of human cells.
from this patient produced human IgG with anti-red cells Chimeric mice receiving PBMC from B-CLL patients with specificity. Immunofixation of serum obtained from chimeric AIHA (Nos 8, 9, 10 and 15), exhibited dominance of tumor mice generated from PBMC of patient No. 8, revealed two cells in their peritoneal cavity (46% ± 22.7) compared to mindifferent clones: one with ␥ and the other with heavy chain uscule levels of T cells (1.8% ± 1.6) (Figure 1 ). Tumor cells specificity (both clones were found to have light chain) could not be detected in internal organs (data not shown).
( Figure 2 ). The production of anti-red cell antibodies was not found to be correlated with the patient's hemolytic activity. Thus, chimeric mice generated from B-CLL patient Nos 6, 8, Anti-human RBC production in human/mouse chimera 12, 14 and 15 which were Coombs'-positive with no hemotransplanted with human PBMC from B-CLL patients lysis, produced anti-red cell antibody levels similar to those with AIHA found in chimeric mice generated from patient Nos 7, 9, 10, 11 and 13 with active hemolysis. Chimeric mice were bled 2-8 weeks after transplantation and their sera were tested for the presence of anti-human RBC.
Immunization of chimeric mice generated from B-CLL patients with or without AIHA failed to produce human anticells, has indicated that these autoantibodies might be produced by the B-CLL B cells via a T cell-independent mech-TT (data not shown).
anism. To examine further this possibility, PBMC of patient No. 15 were depleted of the few T cells typically present in stage 4 patients, by E-rosetting with SRBC, and the purified AIHA antibody production in human/mouse radiation chimera is T cell independent B-CLL cells were then infused into lethally irradiated Balb/c mice ( Figure 3) . Examination of human AIHA antibody in the serum of transThe marked level of AIHA antibody production in human/Balb chimera following infusion of B-CLL cells from stage 4 planted mice showed that T cell depletion did not diminish the antibody response (Table 1) . On the other hand, chimeric patients, which is associated with predominant engraftment of malignant B cells and with minuscule numbers of engrafted T mice genrated from normal PBMC depleted from T cell by E- 
Discussion
Autoimmune diseases which include mainly AIHA demonstrated by positive DAT, has been reported in approximately 20% of all cases of B-CLL patients.
19- 21 The origin of the autoantibodies causing the hemolysis and the mechanisms responsible for the development of autoimmune phenomenon in B-CLL patients have been discussed extensively. 4, [19] [20] [21] [22] [23] [24] The role of CD5
+ lymphocytes in immunoregulation and in mediating autoimmune diseases 23 suggests a causal relationship between clonal B cells and AIHA as seen in cold agglutinin disease where neoplastic B cells always express idiopathic IgM at the cell surface and produce monoclonal IgM protein which matoid factor and RBC specificity were detected in 44% of the engrafted mice. These studies emphasized the ability of
